These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15211588)

  • 21. Mice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity.
    Duclot F; Meffre J; Jacquet C; Gongora C; Maurice T
    Neuroscience; 2010 May; 167(3):850-63. PubMed ID: 20219649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein.
    Zerbinatti CV; Wozniak DF; Cirrito J; Cam JA; Osaka H; Bales KR; Zhuo M; Paul SM; Holtzman DM; Bu G
    Proc Natl Acad Sci U S A; 2004 Jan; 101(4):1075-80. PubMed ID: 14732699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of β-amyloid level in the brain of rats with cerebrovascular hypoperfusion.
    Liu H; Xing A; Wang X; Liu G; Li L
    Neurobiol Aging; 2012 Apr; 33(4):826.e31-42. PubMed ID: 21813211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LRP in amyloid-beta production and metabolism.
    Bu G; Cam J; Zerbinatti C
    Ann N Y Acad Sci; 2006 Nov; 1086():35-53. PubMed ID: 17185504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
    O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
    Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Running exercise delays neurodegeneration in amygdala and hippocampus of Alzheimer's disease (APP/PS1) transgenic mice.
    Lin TW; Shih YH; Chen SJ; Lien CH; Chang CY; Huang TY; Chen SH; Jen CJ; Kuo YM
    Neurobiol Learn Mem; 2015 Feb; 118():189-97. PubMed ID: 25543023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
    Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E
    Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
    De Ferrari GV; Chacón MA; Barría MI; Garrido JL; Godoy JA; Olivares G; Reyes AE; Alvarez A; Bronfman M; Inestrosa NC
    Mol Psychiatry; 2003 Feb; 8(2):195-208. PubMed ID: 12610652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of clathrin-mediated endocytosis prevents amyloid β-induced axonal damage.
    Kuboyama T; Lee YA; Nishiko H; Tohda C
    Neurobiol Aging; 2015 May; 36(5):1808-19. PubMed ID: 25772059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration.
    Park SY; Ferreira A
    J Neurosci; 2005 Jun; 25(22):5365-75. PubMed ID: 15930385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer's disease: A potential therapeutic target?
    Patel P; Shah J
    J Chem Neuroanat; 2017 Nov; 85():36-42. PubMed ID: 28669880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
    Chen X; Hu J; Jiang L; Xu S; Zheng B; Wang C; Zhang J; Wei X; Chang L; Wang Q
    Neuroscience; 2014 Oct; 279():94-101. PubMed ID: 25193238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-O-methylhonokiol attenuated β-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase.
    Lee YK; Choi IS; Ban JO; Lee HJ; Lee US; Han SB; Jung JK; Kim YH; Kim KH; Oh KW; Hong JT
    J Nutr Biochem; 2011 May; 22(5):476-86. PubMed ID: 20688501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinin B2 receptor can play a neuroprotective role in Alzheimer's disease.
    Caetano AL; Dong-Creste KE; Amaral FA; Monteiro-Silva KC; Pesquero JB; Araujo MS; Montor WR; Viel TA; Buck HS
    Neuropeptides; 2015 Oct; 53():51-62. PubMed ID: 26387425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein.
    Hashimoto Y; Chiba T; Yamada M; Nawa M; Kanekura K; Suzuki H; Terashita K; Aiso S; Nishimoto I; Matsuoka M
    Mol Cell Biol; 2005 Nov; 25(21):9304-17. PubMed ID: 16227582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
    Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
    Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease.
    Meunier J; Villard V; Givalois L; Maurice T
    Eur J Pharmacol; 2013 Jan; 698(1-3):193-9. PubMed ID: 23123349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.
    Owen JB; Sultana R; Aluise CD; Erickson MA; Price TO; Bu G; Banks WA; Butterfield DA
    Free Radic Biol Med; 2010 Dec; 49(11):1798-803. PubMed ID: 20869432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.